Wang, J., Tan, J. S. Y., Shelat, V. G., & Lim, J. (2026). IL-6 as a central driver of immune evasion in PDAC: from IDO-mediated tolerance to multi-pathway immunosuppression. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1885999
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers and is characterised by an immunologically “cold” microenvironment that limits responses to immunotherapy. This review focuses on interleukin-6 (IL-6), produced by stromal and immune cells as well as PDAC cells, as a central driver of immune evasion via JAK–STAT3 signalling. We outline how SOCS3 silencing in tumour cells inverts the IL-6–IDO relationship seen in dendritic cells, generating an autocrine IDO–Kyn–AhR–IL-6–STAT3 feedforward loop. We further describe IL-6–mediated stabilisation of PD-L1, sustained PD-1 expression on CD8+T cells, and ST6GAL1-driven hypersialylation that activates Siglec glyco-immune checkpoints. In addition, we examine the IL-6–Blimp-1–IL-10 axis and its reprogramming of dendritic cell and T cell compartments. Given the repeated failure of IL-6(R) blockade in clinical trials, we contrast these outcomes with the more encouraging signals from RAS-targeted strategies. We propose rational IL-6–integrated combinations with upstream oncogenic targeting may represent an unrealised frontier for this disease.
License type:
Attribution 4.0 International (CC BY 4.0)
Funding Info:
This research is supported by core funding from: Singapore Immunology Network,
Grant Reference no. : NA